The Ministry of Health advises that Trinidad and Tobago has exceeded the initial COVID-19 vaccination target as, to date, 42,082 persons have received the first dose of the vaccine.
The remaining doses of the COVID-19 vaccine will be used for the second dose. Thus, the population will be advised when additional doses of the COVID-19 vaccine are available.
Healthcare workers, people with non-communicable diseases and those who are 60 years and older may contact the various COVID-19 Vaccination Facilities, via the call-in or WhatsApp numbers, to be included in the list of eligible persons who are interested in receiving the COVID-19 vaccine when new stock is available.
The Ministry of Health said it will continue to update the public on the roll out of the national COVID-19 vaccination programme.
At this time, the Ministry of Health continues to enforce its policy to retain the stock of doses required to administer the second dose of the vaccine to those who have received the first dose.
The vaccination target was 37,800 or 50% of the 75,600 doses of the WHO approved vaccines that were received to date (2,000 doses donated by the Government of Barbados, 33,600 doses received via the COVAX Facility and 40,000 doses donated by the Government of India.)
As previously reported, vials of COVID-19 vaccines have been found to contain more than the stipulated number of doses, which allowed for the administration of the vaccine to additional people. Therefore, although the target was exceeded, the Ministry is still able to ensure that enough vaccines are held for the second dose.
The Ministry extends its gratitude to the entities and individuals who have provided support to the vaccination drive thus far, including: the committed Management and Staff of the Regional Health Authorities, the Trinidad and Tobago Defence Force, The Trinidad and Tobago Fire Service, the Trinidad and Tobago Police Service, The Trinidad and Tobago Medical Association, the Trinidad and Tobago Registered Nurses Association and all other volunteers and contributors.